Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Post by ready2go1on Apr 28, 2010 11:51am
278 Views
Post# 17039759

All U.S. trades today

All U.S. trades todaySo far 10,000 shares have traded under dgcrf.pk today and they are also reflected under CUR on the tsx. (only 2,000 shares are not) This is how I have always seen these trades carried out in the past. Does not mean much because it is only 10,000 shares but they are buys. One thing for sure, if this number starts to grow, it would show me that those in the States are confident of the impact that PCA3 will have and that FDA approval is a blink away.
     I check everyday to see if Gen-Probe has updated the FDA trial but their last update was in March with a completion date of April. I want them to say this on Thursday.
Bullboard Posts